Eledon Pharmaceuticals (ELDN)
NASDAQ:ELDN
Holding ELDN?
Track your performance easily

Eledon Pharmaceuticals (ELDN) Financial Statements

774 Followers

Eledon Pharmaceuticals Financial Overview

Eledon Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-5.74; its P/E ratio is -0.84; Eledon Pharmaceuticals is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -44.91M$ -10.29M$ -9.63M$ -10.35M$ -9.58M
EBITDA$ -44.81M$ -10.20M$ -9.53M-$ -9.48M
Net Income Common Stockholders$ -44.91M$ -10.29M$ -9.63M$ -10.35M$ -9.58M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 83.61M$ 42.86M$ 51.10M$ 59.61M$ 71.38M
Total Assets$ 120.48M$ 80.82M$ 89.07M$ 96.07M$ 106.78M
Total Debt$ 655.00K$ 284.00K$ 383.00K$ 479.00K$ 574.00K
Net Debt$ -82.95M$ -42.58M$ -50.72M$ -59.13M$ -70.80M
Total Liabilities$ 128.98M$ 6.00M$ 5.65M$ 4.73M$ 6.84M
Stockholders Equity$ -8.50M$ 74.82M$ 83.42M$ 91.33M$ 99.95M
Cash Flow-
Free Cash Flow$ -7.76M$ -8.74M$ -9.13M-$ -8.22M
Operating Cash Flow$ -7.76M$ -8.74M$ -9.13M$ -12.25M$ -8.22M
Investing Cash Flow$ -19.91M$ 9.78M$ 10.08M$ -25.03M$ -30.33M
Financing Cash Flow$ 48.07M$ 1.00K--$ 33.02M
Currency in USD

Eledon Pharmaceuticals Earnings and Revenue History

Eledon Pharmaceuticals Debt to Assets

Eledon Pharmaceuticals Cash Flow

Eledon Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis